These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21127303)

  • 21. Desmoteplase.
    Paciaroni M; Medeiros E; Bogousslavsky J
    Expert Opin Biol Ther; 2009 Jun; 9(6):773-8. PubMed ID: 19456211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragmentation of the classical magnetic resonance mismatch "penumbral" pattern with time.
    Ma H; Zavala JA; Teoh H; Churilov L; Gunawan M; Ly J; Wright P; Phan T; Arakawa S; Davis SM; Donnan GA
    Stroke; 2009 Dec; 40(12):3752-7. PubMed ID: 19850896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
    Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
    Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue.
    Shih LC; Saver JL; Alger JR; Starkman S; Leary MC; Vinuela F; Duckwiler G; Gobin YP; Jahan R; Villablanca JP; Vespa PM; Kidwell CS
    Stroke; 2003 Jun; 34(6):1425-30. PubMed ID: 12738899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
    Ma L; Gao PY; Hu QM; Lin Y; Jing LN; Xue J; Chen ZJ; Wang YJ; Liu ML; Cai YF
    Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial.
    Ringelstein EB; Thijs V; Norrving B; Chamorro A; Aichner F; Grond M; Saver J; Laage R; Schneider A; Rathgeb F; Vogt G; Charissé G; Fiebach JB; Schwab S; Schäbitz WR; Kollmar R; Fisher M; Brozman M; Skoloudik D; Gruber F; Serena Leal J; Veltkamp R; Köhrmann M; Berrouschot J;
    Stroke; 2013 Oct; 44(10):2681-7. PubMed ID: 23963331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total mismatch: negative diffusion-weighted imaging but extensive perfusion defect in acute stroke.
    Cho TH; Hermier M; Alawneh JA; Ritzenthaler T; Desestret V; Østergaard L; Derex L; Baron JC; Nighoghossian N
    Stroke; 2009 Oct; 40(10):3400-2. PubMed ID: 19696413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging.
    Kidwell CS; Saver JL; Mattiello J; Starkman S; Vinuela F; Duckwiler G; Gobin YP; Jahan R; Vespa P; Kalafut M; Alger JR
    Ann Neurol; 2000 Apr; 47(4):462-9. PubMed ID: 10762157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual assessment of perfusion-diffusion mismatch is inadequate to select patients for thrombolysis.
    Campbell BC; Christensen S; Foster SJ; Desmond PM; Parsons MW; Butcher KS; Barber PA; Levi CR; Bladin CF; Donnan GA; Davis SM;
    Cerebrovasc Dis; 2010; 29(6):592-6. PubMed ID: 20389068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke?
    Rivers CS; Wardlaw JM; Armitage PA; Bastin ME; Carpenter TK; Cvoro V; Hand PJ; Dennis MS
    Stroke; 2006 Jan; 37(1):98-104. PubMed ID: 16322499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.
    Parsons MW; Miteff F; Bateman GA; Spratt N; Loiselle A; Attia J; Levi CR
    Neurology; 2009 Mar; 72(10):915-21. PubMed ID: 19273826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials.
    Warach S; Al-Rawi Y; Furlan AJ; Fiebach JB; Wintermark M; Lindstén A; Smyej J; Bharucha DB; Pedraza S; Rowley HA
    Stroke; 2012 Sep; 43(9):2313-8. PubMed ID: 22738918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of subacute infarct size in acute middle cerebral artery stroke: comparison of perfusion-weighted imaging and apparent diffusion coefficient maps.
    Drier A; Tourdias T; Attal Y; Sibon I; Mutlu G; Lehéricy S; Samson Y; Chiras J; Dormont D; Orgogozo JM; Dousset V; Rosso C
    Radiology; 2012 Nov; 265(2):511-7. PubMed ID: 22923715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluid-Attenuated Inversion Recovery Vascular Hyperintensities-Diffusion-Weighted Imaging Mismatch Identifies Acute Stroke Patients Most Likely to Benefit From Recanalization.
    Legrand L; Tisserand M; Turc G; Edjlali M; Calvet D; Trystram D; Roca P; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
    Stroke; 2016 Feb; 47(2):424-7. PubMed ID: 26732567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion.
    Wheeler HM; Mlynash M; Inoue M; Tipirnini A; Liggins J; Bammer R; Lansberg MG; Kemp S; Zaharchuk G; Straka M; Albers GW;
    Int J Stroke; 2015 Jul; 10(5):723-9. PubMed ID: 25580662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point.
    Ebinger M; Christensen S; De Silva DA; Parsons MW; Levi CR; Butcher KS; Bladin CF; Barber PA; Donnan GA; Davis SM;
    Stroke; 2009 Apr; 40(4):1353-8. PubMed ID: 19246703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.